{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:06:11Z","timestamp":1789473971042,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.endien.2026.501846","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:27:56Z","timestamp":1784068076000},"page":"501846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Knowledge and management of metabolic dysfunction-associated steatotic liver disease among endocrinologists in Spain"],"prefix":"10.1016","volume":"73","author":[{"given":"Mar\u00eda Teresa","family":"Juli\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Rubio-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Escalada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2026.501846_bib0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.endien.2026.501846_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.16381","article-title":"Metabolic dysfunction-associated steatotic liver disease\u2014the new epidemic of chronic liver disease","volume":"8","author":"Gin\u00e8s","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.endien.2026.501846_bib0015","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"2441","key":"10.1016\/j.endien.2026.501846_bib0020","article-title":"Clinical and economic burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Spanish Mediterranean Region: a population-based study","volume":"14","author":"D\u00edaz Carnicero","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.endien.2026.501846_bib0025","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.endien.2026.501846_bib0030","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.endien.2026.501846_bib0035","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.endien.2026.501846_bib0040","article-title":"Non-alcoholic fatty liver disease: a patient guideline","volume":"3","author":"Francque","year":"2021","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.endien.2026.501846_bib0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.endien.2026.501846_bib0050","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","article-title":"Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis","volume":"72","author":"En Li Cho","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.endien.2026.501846_bib0055","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American Diabetes Association","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2026.501846_bib0060","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.endien.2026.501846_bib0065","article-title":"Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: a population-based study","volume":"13","author":"Juli\u00e1n","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.endien.2026.501846_bib0070","article-title":"Predictors of fibrosis, clinical events and mortality in MASLD: data from the Global-MASLD study","author":"Younossi","year":"2025","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.endien.2026.501846_bib0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.endinu.2024.01.006","article-title":"Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists","volume":"71","author":"Mauricio","year":"2024","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2026.501846_bib0080","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000704","article-title":"Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in 4 major cities in the United States","volume":"9","author":"Lazarus","year":"2025","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.endien.2026.501846_bib0085","article-title":"[Survey on knowledge of metabolic liver disease (EHMet) among Primary Care Physicians in Spain]","volume":"51","author":"Exp\u00f3sito Mart\u00ednez","year":"2025","journal-title":"Semergen"},{"key":"10.1016\/j.endien.2026.501846_bib0090","doi-asserted-by":"crossref","first-page":"e1456","DOI":"10.1016\/j.cgh.2021.06.048","article-title":"A global survey of physicians knowledge about nonalcoholic fatty liver disease","volume":"20","author":"Younossi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.endien.2026.501846_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101569","article-title":"Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region","volume":"30","author":"Alqahtani","year":"2025","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.endien.2026.501846_bib0100","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ueg2.12445","article-title":"A global survey of health care workers\u2019 awareness of non-alcoholic fatty liver disease: the AwareNASH survey","volume":"11","author":"Driessen","year":"2023","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.endien.2026.501846_bib0105","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.2337\/dc25-S004","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2026.501846_bib0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.endinu.2018.10.010","article-title":"Document on a comprehensive approach to type 2 diabetes mellitus","volume":"66","author":"Reyes-Garc\u00eda","year":"2019","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2026.501846_bib0115","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.endinu.2020.05.003","article-title":"The SEEN comprehensive clinical survey of adult obesity: executive summary","volume":"68","author":"Ballesteros Pomar","year":"2021","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2026.501846_bib0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000496183","article-title":"European practical and patient-centred guidelines for adult obesity management in primary care","volume":"12","author":"Durrer Schutz","year":"2019","journal-title":"Obes Facts"},{"key":"10.1016\/j.endien.2026.501846_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254939","article-title":"Prospective screening of liver fibrosis in a primary care cohort using systematic calculation of fib-4 in routine results","volume":"16","author":"Halfon","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.endien.2026.501846_bib0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-62549-3","article-title":"Using the FIB-4, automatically calculated, followed by the ELF test in second line to screen primary care patients for liver disease","volume":"14","author":"Ouzan","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.endien.2026.501846_bib0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-66210-x","article-title":"Early screening for chronic liver disease: impact of a FIB-4 first integrated care pathway to identify patients with significant fibrosis","volume":"14","author":"Mignot","year":"2024","journal-title":"Sci Rep"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018026001393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018026001393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:40:18Z","timestamp":1789472418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018026001393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2530018026001393"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2026.501846","relation":{},"ISSN":["2530-0180"],"issn-type":[{"value":"2530-0180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knowledge and management of metabolic dysfunction-associated steatotic liver disease among endocrinologists in Spain","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2026.501846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2026.501846","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501846"}}